Diagnosing Epilepsy To EffeCT Change

Clinical trial NCT07110337 · RECRUITING

Trial details

NCT number: NCT07110337
Sponsor: Epiminder America, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Epilepsy Epilepsy (Treatment Refractory)

Start date: 2025-12-23
Primary completion: 2027-06-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.